Skip to main content
Veeva Systems Inc (VEEV)
Computer Software and Services Information Technology
Stock AI

Veeva Systems to Showcase AI Innovations at Commercial Summit

Last updated: May 14, 2026
Taurigo

1. Introduction to the Summit

Veeva Systems Inc. (NYSE: VEEV) is set to host its highly anticipated Veeva Commercial Summit on May 19-20, 2026, in Boston. This year, the summit will focus on the transformative potential of artificial intelligence (AI) in the biopharmaceutical industry, particularly as companies strive towards what Veeva refers to as "Agentic Commercial." With participation from industry leaders including argenx, Bayer, Boehringer Ingelheim, Genentech, Gilead, GSK, Merck, Novo Nordisk, Takeda, and Vertex, the summit promises to deliver valuable insights into current trends and future directions in commercial engagement.

2. Embracing Agentic Commercial

Veeva's vision for Agentic Commercial integrates industry-specific AI, data, and applications aimed at enhancing the pharmaceutical industry's ability to deliver effective medicines to patients. The summit will feature over 100 sessions where executives from leading biopharma companies will share their experiences and strategies for leveraging AI and data to improve customer engagement and drive measurable value.

Key Themes and Highlights

The summit will explore several critical themes, including:

Accelerating Agentic Commercial at Scale

  • Innovative CRM Solutions: Genentech, Gilead, and Novo Nordisk will present how they are utilizing next-generation Customer Relationship Management (CRM) systems to fuel innovation.
  • Shaping Customer Engagement: GSK will outline its vision for customer engagement using Vault CRM and Veeva AI, showcasing how technology can enhance interactions.
  • Content Strategy for Quality Reviews: Avidity Biosciences, a Novartis Company, and Boehringer Ingelheim will discuss their agentic content strategy that expedites quality reviews, enabling faster decision-making.
  • Instant Information Access: Gilead and Boehringer Ingelheim are set to unveil solutions that provide doctors and patients with immediate, compliant responses to their queries.

Precision Data and AI Integration

  • Deep Data Utilization: Merck and Takeda will share insights on integrating deep data to enhance business processes and AI functionalities.
  • Patient Engagement: Companies like MoonLake and Unicycive will demonstrate how modern data can rapidly identify and engage patients effectively.
  • Media Measurement Framework: argenx will present its framework for measuring media effectiveness in its direct-to-consumer launch strategy.

Medical Affairs and Patient Outcomes

  • Modern Operating Systems: GSK and Vertex will discuss their efforts in establishing a modern operating system for medical affairs, aimed at driving impactful outcomes.
  • Sharing Medical Insights: Astellas, Bayer, and Chiesi USA will focus on the importance of capturing and disseminating medical insights to foster actionable strategies.

3. Attendance and Sponsorship

The Veeva Commercial Summit is expected to attract over 2,000 professionals from the life sciences sector, making it the largest commercial and medical event in North America. The event boasts more than 40 sponsoring partners, including renowned firms like Accenture, Conexus, Cognizant, EY, IQVIA, and Slipstream. Registration is exclusive to life sciences professionals, and interested parties can secure their spots at veeva.com/Summit.

4. About Veeva Systems

Veeva Systems is a leading provider of cloud-based software solutions tailored for the life sciences sector. With a commitment to innovation and customer success, Veeva serves over 1,500 clients, including some of the largest pharmaceutical companies and emerging biotech firms. As a Public Benefit Corporation, Veeva prioritizes the interests of all stakeholders—customers, employees, shareholders, and the broader industry.

This summit represents a significant opportunity for professionals in the biopharmaceutical industry to gather insights, share experiences, and explore the future of commercial engagement powered by AI and data.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.